The results illustrated that the anti-PD-1 treatment alone only slightly suppressed tumor growth (Fig. 8b–e), possibly due to the limited T cell infiltration in the immunosuppressive TME of B16F10 melanoma. The gene discussed is PDCD1; the disease is melanoma.